Plasma androgen receptor and response to adapted and standard docetaxel regimen in castration-resistant prostate cancer: A multicenter biomarker study (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ejca.2021.04.025
PubMed Identifier: 34077818
Publication URI: http://europepmc.org/abstract/MED/34077818
Type: Journal Article/Review
Parent Publication: European Journal of Cancer
ISSN: 0959-8049